SCHEMBL6003712

SCHEMBL6003712

CCCCCCC(I)(C(=O)O)C(I)(CCCCCC)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GGPS1 O95749 1/20 0.48
CES2 O00748 1/20 0.45
GPR84 Q9NQS5 7/20 0.44
PPARG P37231 7/20 0.44
PPARD Q03181 7/20 0.44
PPARA Q07869 7/20 0.44
HDAC11 Q96DB2 5/20 0.44
TSHR P16473 4/20 0.44
PTPN1 P18031 3/20 0.44
ALDH1A1 P00352 2/20 0.44
TLR2 O60603 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
FABP4 P15090 2/20 0.44
SLC22A6 Q4U2R8 1/20 0.44
SLC22A8 Q8TCC7 1/20 0.44
MEN1 O00255 1/20 0.44
ESR1 P03372 1/20 0.44
ALOX15 P16050 1/20 0.44
PDE4A P27815 1/20 0.44
KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6003347 0.98 GGPS1 (0.45) GGPS1CES2GPR84PPARGPPARD
SCHEMBL6003106 0.91 AKR1B1 (0.39) GGPS1GPR84PPARGPPARDPPARA
SCHEMBL10392694 0.82 GGPS1 (0.48) GGPS1CES2GPR84PPARGPPARD
SCHEMBL11196635 0.82 GGPS1 (0.48) GGPS1CES2GPR84PPARGPPARD
SCHEMBL6003046 0.80 FFAR3 (0.35) CES2TSHRALDH1A1TDP1MEN1
SCHEMBL11663619 0.80 GGPS1 (0.47) GGPS1CES2GPR84PPARGPPARD
SCHEMBL27419488 0.80 GGPS1 (0.47) GGPS1CES2GPR84PPARGPPARD
SCHEMBL9153322 0.79 GGPS1 (0.50) GGPS1CES2GPR84PPARGPPARD
SCHEMBL9500045 0.79 GGPS1 (0.50) GGPS1CES2GPR84PPARGPPARD
SCHEMBL10339977 0.79 GGPS1 (0.50) GGPS1CES2GPR84PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060217565-A1 Process for producing chromone compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-09-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060217565-A1 Process for producing chromone compound ENY2, CDY1; CDY1B, CDYL GGPS1 2718/4885CES2 449/4885GPR84 2306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.